We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2023
Programme
RTT treatment planning, OAR and target...
12 May 2023 - 16 May 2023
Vienna, Austria
ESTRO 2023
Session
RTT treatment planning, OAR and target definitions
Session Type:
Poster (Digital)
Track:
RTT
Journey:
Add to
My Programme
A novel tool to evaluate and quantify radiation induced lung injury(RILI): volume of pneumonia patch
Yihui Lin
,
Taiwan
Presentation Number:
PO-2322
The efficiency of Atlas-Based Segmentation for head and neck patients used in RayStation
Lisanne van Klaveren
,
Switzerland
Presentation Number:
PO-2324
The relationship between contour agreement and dosimetric impacts in CBCT for prostate radiotherapy
Helen Pang
,
Hong Kong (SAR) China
Presentation Number:
PO-2325
Evaluating the use of planning PET in radiotherapy treatment planning for rectal cancer
Yujia Gao
,
United Kingdom
Presentation Number:
PO-2326
Brain Metastases SRS: Single-isocentre VMAT vs Multi-isocentre Dynamic Conformal Arc
Phyllis Ching Laam Leung
,
Hong Kong (SAR) China
Presentation Number:
PO-2328
Role of deep inspiration breath hold on post-operative radiotherapy of right-sided breast cancer
Benedict Ian Torno
,
Philippines
Presentation Number:
PO-2329
Dose metrics of the brachial plexus in post-mastectomy radiotherapy of breast cancer
Benedict Ian Torno
,
Philippines
Presentation Number:
PO-2330
Evaluating efficiency of Vertical MLC VMAT plan for nasopharyngeal carcinoma
Seung hoon Chae
,
Korea Republic of
Presentation Number:
PO-2331
Should we limit the maximum dose in inverse-planning-based lung SBRT plans?
Cristina Castro
,
Spain
Presentation Number:
PO-2332
Consensus spanish GINECOR group: Technical aspects in vulvar cancer radiotherapy. A delphy study
Sofia Cordoba Largo
,
Spain
Presentation Number:
PO-2333
Cardiac conduction nodes exposure in hypofractionated left-sided breast cancer radiotherapy
Zeineb Naimi
,
Tunisia
Presentation Number:
PO-2334
A retrospective comparison: free breathing v deep inspiration radiotherapy in right breast cancer
Theresa O'Donovan
,
Ireland
Presentation Number:
PO-2335
Breast cancer radiotherapy and oesophagus radiation exposure: Is it a trivialized concern?
Zeineb Naimi
,
Tunisia
Presentation Number:
PO-2336
Does gastric volume impact lung’s exposure in loco-regional left-sided breast cancer radiotherapy?
Zeineb Naimi
,
Tunisia
Presentation Number:
PO-2338
Analysing the feasibility of adapted MR-guided SABR for prostate cancer patients with hip prosthesis
Addalin Huynh
,
United Kingdom
Presentation Number:
PO-2339
The emerging role of radiation therapists in contouring organs at risk for rectal cancer.
Poonam Negi
,
India
Presentation Number:
PO-2340
Dose reduction for normal tissue from daily CBCT doing radiation treatment for young patients
Troels Lautrup
,
Denmark
Presentation Number:
PO-2342
quantification of organ motion with magnetic resonance in carbon ion therapy of the abdominal tumors
Luca Anemoni
,
Italy
Presentation Number:
PO-2343
Curative reRT for patients with recurrent head and neck adenoid cystic carcinomas
Valentin Calugaru
,
France
Presentation Number:
PO-2344
Evaluation of manual and DirectOrgans algorithm for delineation of OAR in thorax radiation therapy
Maja Sand
,
Denmark
Presentation Number:
PO-2345
Dosimetric study of radiation dose to external auditory canal among nasopharyngeal cancer survivors
Sum Yin Serene Ho
,
Hong Kong (SAR) China
Presentation Number:
PO-2346
Bladder wall dose in PCa patients treated with stereotactic, daily adaptive MR-guided radiotherapy
Eline de Groot - van Breugel
,
The Netherlands
Presentation Number:
PO-2347
SCOPE1 RTTQA - assessing adherence to tumour volume delineation guidelines
Rhiannon Evans
,
United Kingdom
Presentation Number:
PO-2352
Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer
Nejla Fourati
,
Tunisia
Presentation Number:
PO-2353
Internal guidelines to reduce lymph-node contour variability for total marrow/lymph node irradiation
Damiano Dei
,
Italy
Presentation Number:
PO-2355
therapeutic radiographer contouring of target volumes for low and intermediate risk prostate cancer
Susannah Jansen van Rensburg
,
United Kingdom
Presentation Number:
PO-2356
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.